Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
4-Deschloro-2-chloro-Sorafenib is a derivative of Sorafenib (S676850), a multiple kinase inhibitor targeting both RAF kinase and receptor tyrosine kinases that promote angiogensis. Antineoplastic.
?您的位置：
